{"protocolSection":{"identificationModule":{"nctId":"NCT04162743","orgStudyIdInfo":{"id":"CMRPG2I0021"},"organization":{"fullName":"Chang Gung Memorial Hospital","class":"OTHER"},"briefTitle":"The Effect of Trazodone on the Severity of Obstructive Sleep Apnea in Insomnic Stroke Patients With Depression","officialTitle":"The Effect of Trazodone on the Severity of Obstructive Sleep Apnea in Insomnic Stroke Patients With Depression"},"statusModule":{"statusVerifiedDate":"2020-04","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2019-02-01","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2020-03-31","type":"ACTUAL"},"completionDateStruct":{"date":"2020-03-31","type":"ACTUAL"},"studyFirstSubmitDate":"2019-11-10","studyFirstSubmitQcDate":"2019-11-13","studyFirstPostDateStruct":{"date":"2019-11-14","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-04-03","lastUpdatePostDateStruct":{"date":"2020-04-06","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"CHEN,CHUNG YAO","investigatorTitle":"doctor","investigatorAffiliation":"Chang Gung Memorial Hospital"},"leadSponsor":{"name":"Chang Gung Memorial Hospital","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The investigators hypothesize that trazodone does not worse nocturnal oxygen saturation in insomnic ischemic stroke patients with obstructive sleep apnea (OSA) and depression and has beneficial effect in selected stroke patients with low arousal threshold phenotype OSA."},"conditionsModule":{"conditions":["Sleep Apnea Syndromes","Cerebral Infarction"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"CROSSOVER","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":22,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Trazodone","type":"ACTIVE_COMPARATOR","description":"take trazodone 100mg hs","interventionNames":["Drug: Trazodone"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","description":"take placebo pill hs","interventionNames":["Drug: Placebo oral tablet"]}],"interventions":[{"type":"DRUG","name":"Trazodone","description":"take trazodone 100mg before polysomnography","armGroupLabels":["Trazodone"]},{"type":"DRUG","name":"Placebo oral tablet","description":"take placebo oral tablet before polysomnography","armGroupLabels":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"nocturnal oxygen saturation","description":"mean and minimum oxyhemoglobin saturation (%) detected by pulse oximetry during polysomnography study","timeFrame":"the polysomnography study night before take drug"},{"measure":"Sleep apnea severity index","description":"apnea-hypopnea index, desaturation index according to The American Academy of Sleep Medicine (AASM) scoring manual version 2.0.3: Obstructive apnea: no airflow \\>= 10 s with respiratory effort (per hour of time); central apnea: no airflow without respiratory effort (per hour of time). Hypopnea: airflow decrease \\>30% lasting \\>= 10 s, followed by either oxygen desaturation \\> 3% or EEG arousal (per hour of time). The desaturation index: number of desaturations per hour of time.","timeFrame":"the polysomnography study night before take drug"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Insomnic ischemic stroke patients with OSA and depression.\n\nExclusion Criteria:\n\n* unclear consciousness, unstable vital sign or neurologic sign, unstable medical conditions such as delirium, active infection, evidence of overt congestive cardiac failure, liver dysfunction with ascites, thyroid disease, end-stage-renal-disease receiving dialysis.\n* overnight mean oxygen saturation (SaO2) nadir is â‰¤ 70% at baseline\n* take monoamine oxidase inhibitors (MAOI), any medication that may affect breathing, sleep, or muscle activity\n* any known allergy to trazodone\n* sleep disorder other than OSA (e.g., periodic leg movement syndrome, restless legs syndrome, central sleep apnea/Cheyne-Stokes respiration).","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Chang Gung Memorial Hospital, Keelung","city":"Keelung","country":"Taiwan","geoPoint":{"lat":25.12825,"lon":121.7419}}]},"referencesModule":{"references":[{"pmid":"33625584","type":"DERIVED","citation":"Chen CY, Chen CL, Yu CC. Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study. J Neurol. 2021 Aug;268(8):2951-2960. doi: 10.1007/s00415-021-10480-2. Epub 2021 Feb 24."}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001049","term":"Apnea"},{"id":"D000012891","term":"Sleep Apnea Syndromes"},{"id":"D000020181","term":"Sleep Apnea, Obstructive"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007238","term":"Infarction"}],"ancestors":[{"id":"D000012120","term":"Respiration Disorders"},{"id":"D000012140","term":"Respiratory Tract Diseases"},{"id":"D000012818","term":"Signs and Symptoms, Respiratory"},{"id":"D000007511","term":"Ischemia"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000009336","term":"Necrosis"},{"id":"D000020919","term":"Sleep Disorders, Intrinsic"},{"id":"D000020920","term":"Dyssomnias"},{"id":"D000012893","term":"Sleep Wake Disorders"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000020521","term":"Stroke"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M6748","name":"Depression","relevance":"LOW"},{"id":"M6751","name":"Depressive Disorder","relevance":"LOW"},{"id":"M4051","name":"Apnea","asFound":"Apnea","relevance":"HIGH"},{"id":"M15384","name":"Sleep Apnea Syndromes","asFound":"Sleep Apnea","relevance":"HIGH"},{"id":"M21700","name":"Sleep Apnea, Obstructive","asFound":"Obstructive Sleep Apnea","relevance":"HIGH"},{"id":"M16045","name":"Syndrome","relevance":"LOW"},{"id":"M9972","name":"Infarction","asFound":"Infarction","relevance":"HIGH"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Cerebral Infarction","relevance":"HIGH"},{"id":"M14647","name":"Respiration Disorders","relevance":"LOW"},{"id":"M14667","name":"Respiratory Tract Diseases","relevance":"LOW"},{"id":"M15313","name":"Signs and Symptoms, Respiratory","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"M21932","name":"Parasomnias","relevance":"LOW"},{"id":"M22344","name":"Sleep Disorders, Intrinsic","relevance":"LOW"},{"id":"M22345","name":"Dyssomnias","relevance":"LOW"},{"id":"M15386","name":"Sleep Wake Disorders","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"},{"abbrev":"BC08","name":"Respiratory Tract (Lung and Bronchial) Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000014196","term":"Trazodone"}],"ancestors":[{"id":"D000014151","term":"Anti-Anxiety Agents"},{"id":"D000014149","term":"Tranquilizing Agents"},{"id":"D000002492","term":"Central Nervous System Depressants"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000011619","term":"Psychotropic Drugs"},{"id":"D000017367","term":"Selective Serotonin Reuptake Inhibitors"},{"id":"D000014179","term":"Neurotransmitter Uptake Inhibitors"},{"id":"D000049990","term":"Membrane Transport Modulators"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000018377","term":"Neurotransmitter Agents"},{"id":"D000018490","term":"Serotonin Agents"},{"id":"D000018687","term":"Antidepressive Agents, Second-Generation"},{"id":"D000000928","term":"Antidepressive Agents"}],"browseLeaves":[{"id":"M16640","name":"Trazodone","asFound":"Local infiltration","relevance":"HIGH"},{"id":"M16595","name":"Anti-Anxiety Agents","relevance":"LOW"},{"id":"M14164","name":"Psychotropic Drugs","relevance":"LOW"},{"id":"M15202","name":"Serotonin","relevance":"LOW"},{"id":"M19339","name":"Selective Serotonin Reuptake Inhibitors","relevance":"LOW"},{"id":"M20194","name":"Neurotransmitter Agents","relevance":"LOW"},{"id":"M3937","name":"Antidepressive Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"CNSDep","name":"Central Nervous System Depressants"},{"abbrev":"PsychDr","name":"Psychotropic Drugs"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}